Mode
Text Size
Log in / Sign up

Meta-analysis finds mHealth interventions may improve eHealth literacy in chronic disease patientsSmartphone Apps Help Patients Understand Their Health Better

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that mHealth interventions may improve eHealth literacy in chronic disease patients, but evidence is moderate and context-dependent.

This is a systematic review and meta-analysis of randomized controlled trials (RCTs) and quasi-experimental studies evaluating mHealth interventions for patients with chronic diseases. The analysis synthesized evidence from a total sample size of 2,884 patients. The setting and specific chronic conditions were not reported in the source data. The intervention consisted of mHealth interventions, while the comparator was not reported. The primary outcome was eHealth literacy.

The main result from the RCTs indicated that mHealth interventions could improve eHealth literacy, with a pooled standardized mean difference (SMD) of 1.19 (95% CI 0.14-2.23; P=.03). This represents a statistically significant improvement. Subgroup analyses provided further detail: interventions targeting patients with specific diseases produced larger mean effects (SMD=1.61; 95% CI 0.16-3.06), while interventions targeting general chronic disease populations produced smaller effects (SMD=0.36; 95% CI 0-0.73). For intervention duration, a combined effect was statistically significant for durations less than 3 months (SMD=0.61; 95% CI 0.09-1.13), but the combined effect was not statistically significant for durations of 3 months or longer (effect size and p-value not reported).

Key secondary outcomes were not reported in the provided data. Safety and tolerability findings were also not reported; adverse events, serious adverse events, and discontinuations were all noted as not reported.

These results can be compared to prior landmark studies in therapeutic areas involving digital health interventions. The source does not provide a direct comparison, but the current meta-analysis highlights the potential of mHealth to improve eHealth literacy, a key component of patient self-management. The certainty of RCT evidence was moderate, while the certainty of quasi-experimental evidence was low, as noted in the limitations.

Key methodological limitations include substantial heterogeneity among the included studies, which affects the reliability of the pooled estimates. The effectiveness of mHealth interventions is highly context-dependent and closely linked to implementation factors. The certainty of the evidence was moderate for RCTs and low for quasi-experimental studies, indicating potential bias and uncertainty in the findings.

The clinical implications emphasize the need for evidence-based intervention programs and more rigorous implementation of intervention designs in future research. However, clinicians should not infer specific clinical outcomes beyond eHealth literacy, as the analysis focused solely on this outcome. The generalizability of findings is limited by heterogeneity and prediction intervals.

Unanswered questions remain regarding the long-term sustainability of eHealth literacy improvements, the optimal duration and design of mHealth interventions for different chronic conditions, and the impact of these interventions on actual clinical outcomes such as hospitalizations or quality of life. Future research should address these gaps with more rigorous study designs and standardized reporting.

  • Apps boost health knowledge in chronic illness patients
  • Helps those with long-term conditions manage care
  • Not all apps work the same—results vary widely

This could change how patients learn about their health using phones.

You get a diagnosis. Now what? Many people turn to Google. But not all online health info is clear or trustworthy. For patients with long-term illnesses like diabetes or heart disease, knowing what to believe can be overwhelming.

But help may be closer than they think—right in their pockets.

Millions live with chronic diseases. These include diabetes, high blood pressure, COPD, and heart failure. Patients often need to make daily health choices. What to eat. When to take meds. When to call a doctor.

Yet many struggle to understand medical terms or find reliable info online. This is called low eHealth literacy. It’s not about being smart. It’s about having the right tools and support.

Today, nearly everyone has a smartphone. But having access doesn’t mean knowing how to use it for health.

Current tools often fall short. Brochures go unread. Websites are too complex. Doctor visits are brief. Patients leave confused.

We need better ways to empower people—especially those managing illness every day.

The missing link

For years, doctors hoped tech would fix the gap. Apps were launched. Text alerts sent. Online portals created.

But early efforts didn’t always help. Some apps were hard to use. Others gave too much info at once. Many patients stopped using them.

Researchers began asking: What if the problem isn’t the patient—but how the tools are built?

The surprising shift

Here’s the twist: not all mHealth apps fail. Some actually work—very well.

A new review of 15 studies shows that smartphone-based programs can improve eHealth literacy. That means patients get better at finding, understanding, and using online health info.

But—and this is key—not every app delivers the same results.

What works—and what doesn’t

The most effective apps focus on one specific disease. Think: a diabetes-only program, not a general “be healthier” app.

These targeted tools guide users step by step. They use simple language. They send reminders. Some even include videos or quizzes.

It’s like having a personal coach in your phone.

One study showed patients using a custom heart failure app learned faster. They understood lab results. They knew when to seek help. Their confidence grew.

But general health apps? They had much smaller effects.

Think of eHealth literacy like a lock and key.

The lock is the health system—full of complex terms, websites, and choices. The key is the patient’s ability to open that door and get what they need.

An effective app doesn’t just hand over the key. It teaches the patient how to use it.

It breaks down jargon. (“HbA1c” becomes “your average blood sugar over 3 months.”) It guides users to trusted sources. It checks understanding—like a teacher giving a quick quiz.

Over time, patients feel more in control.

Researchers reviewed data from over 2,800 patients across 15 studies. Most had conditions like diabetes, heart disease, or kidney failure.

They tested apps, text messaging programs, and online platforms. Some lasted 4 weeks. Others ran for 6 months.

The best results came from short-term programs—under 3 months. Longer ones didn’t show clear benefits.

On average, patients using mHealth tools improved their eHealth literacy. The effect was moderate but meaningful.

In one analysis, the improvement was large enough to help patients make better decisions—like when to call a doctor or how to adjust insulin.

But the results varied widely. Some patients gained a lot. Others saw little change.

The strongest gains came from apps designed for a single disease and used for less than 90 days.

This doesn’t mean this treatment is available yet.

But there’s a catch.

The success of these apps depends on how they’re built and used.

Some studies had small groups. Others lacked control groups. The quality of evidence is only moderate.

Also, most research happened in high-income countries. We don’t yet know how well these tools work in areas with poor internet or low smartphone access.

What scientists didn’t expect

Even well-designed apps failed when patients didn’t engage. If the content felt irrelevant or the interface was clunky, people stopped using them.

The biggest factor wasn’t the tech—it was trust.

Patients were more likely to stick with apps that felt personal. That respected their time. That didn’t overwhelm them.

No single app is right for everyone. But if you have a chronic condition, a well-built mHealth tool could help you understand your health better.

Ask your doctor about trusted apps. Look for ones designed for your specific condition. Try them for a few weeks.

Don’t expect miracles. But do expect progress.

These tools aren’t replacements for care. They’re helpers—like a GPS for your health journey.

More research is needed. Scientists must test which features work best. Who benefits most? How long should programs last?

Future apps may use AI to personalize content. Others could link directly to your medical record—with your permission.

For now, the message is clear: mHealth can help. But only if it’s built with patients—not just technology—in mind.

Study Details

Study typeMeta analysis
Sample sizen = 2,884
EvidenceLevel 1
Follow-up3.0 mo
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: With the widespread use of the internet and mobile devices, eHealth literacy promotion is critical for medical equity. Mobile health (mHealth) serves as a pivotal tool for enhancing eHealth literacy by providing accessible, interactive platforms for health information engagement. However, the evidence regarding the effectiveness of mHealth interventions on eHealth literacy among patients with chronic diseases remains inconclusive. OBJECTIVE: This study aimed to evaluate the effectiveness of mHealth interventions on eHealth literacy among patients with chronic diseases based on randomized controlled trials (RCTs) and summarize supportive evidence from quasi-experimental and qualitative studies. METHODS: A comprehensive search strategy was developed, and 8 electronic databases were systematically searched for studies published up to February 12, 2026. Patients with chronic diseases were included based on predefined inclusion criteria. The Cochrane risk of bias 2 tool for RCTs and the ROBINS-I tool for quasi-experimental studies were used to assess the risk of bias. Given the anticipated substantial heterogeneity among the studies included, we used a random-effects model based on the Hartung-Knapp-Sidik-Jonkman method to pool effect sizes. A narrative and quantitative synthesis of the findings was provided where appropriate. RESULTS: A total of 15 studies were included in this review, including 6 RCTs, 5 quasi-experimental studies, and 4 qualitative studies, involving a total of 2884 patients with chronic diseases. Meta-analyses of RCTs suggested that mHealth interventions could improve eHealth literacy, with a pooled mean effect size of standardized mean difference (SMD)=1. 19 (95% CI 0.14-2.23; P=.03; I²=97.75%; PI [prediction interval]=-2.68 to 5.05). Subgroup analyses by intervention targets showed that interventions on targets with specific disease produced larger mean effects (SMD=1.61; 95% CI 0.16-3.06; PI=-5.40 to 8.63), while interventions targeting the population with general chronic diseases produced smaller effects (SMD=0.36; 95% CI 0-0. 73; PI=-0. 21 to 0. 94). Analysis by intervention duration subgroup showed that the combined effect of studies with intervention duration <3 months was statistically significant (SMD=0.61; 95% CI 0.09-1.13; I²=88.04%; PI=-5.72 to 6.95); while the combined effect of studies with intervention duration ≥3 months was not statistically significant. Taking into account bias and the risk of GRADE (Grading of Recommendations, Assessment, Development, and Evaluation), the certainty of RCT evidence was moderate, and the certainty of quasi-experimental evidence was low. CONCLUSIONS: mHealth interventions could improve eHealth literacy among patients with chronic diseases on average. By using prediction intervals, this study reveals that the effectiveness of mHealth interventions is highly context-dependent and closely linked to implementation factors. Advancing beyond prior work, this study centers on eHealth literacy as a core outcome and integrates multiple types of evidence. Meanwhile, this finding emphasizes the need for evidence-based intervention programs and more rigorous implementation of intervention designs in future research.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.